Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Trading Up 1.5 %

MLSS opened at $1.03 on Friday. The stock’s fifty day simple moving average is $0.84 and its 200 day simple moving average is $0.88. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10. The stock has a market cap of $80.23 million, a PE ratio of -14.71 and a beta of 1.10.

Insider Buying and Selling

In related news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 24.75% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of MLSS. Y Intercept Hong Kong Ltd bought a new position in Milestone Scientific during the 3rd quarter worth approximately $48,000. World Investment Advisors LLC acquired a new position in Milestone Scientific in the third quarter valued at $91,000. Finally, Geode Capital Management LLC boosted its position in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares during the last quarter. 5.79% of the stock is owned by institutional investors and hedge funds.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.